Stay updated on Low Dose Ipilimumab With Pembrolizumab in Brain Metastases Clinical Trial
Sign up to get notified when there's something new on the Low Dose Ipilimumab With Pembrolizumab in Brain Metastases Clinical Trial page.

Latest updates to the Low Dose Ipilimumab With Pembrolizumab in Brain Metastases Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe page revision label was updated to v3.6.5, indicating a new published revision of the page. This update does not modify the study content or details.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe page revision metadata was updated from v3.6.3 to v3.6.4. This indicates a newer version of the page with minor updates or fixes.SummaryDifference0.1%

- Check55 days agoChange DetectedThe page shows a new revision tag (v3.6.3) replacing the previous v3.6.2, indicating a small maintenance update.SummaryDifference0.1%

- Check62 days agoChange DetectedThe page's revision label changed from v3.6.0 to v3.6.2, signaling a small backend/template update rather than changes to the study information.SummaryDifference0.1%

- Check77 days agoChange DetectedRecruitment status now indicates the study is not enrolling; new user guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) and a standardized Intervention/Treatment heading with an updated Revision: v3.6.0 are added, while an older Intervention / Treatment heading and the previous revision label are removed.SummaryDifference0.4%

- Check84 days agoChange DetectedThe page's revision tag was updated from v3.5.4 to v3.5.5, marking a new version of the page. This appears to be an administrative update rather than a change to displayed information.SummaryDifference0.1%

Stay in the know with updates to Low Dose Ipilimumab With Pembrolizumab in Brain Metastases Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Low Dose Ipilimumab With Pembrolizumab in Brain Metastases Clinical Trial page.